Caris Life Sciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CAI and other ETFs, options, and stocks.

About CAI

Caris Life Sciences, Inc. provides diagnostics and anatomic pathology services. It develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects.

CEO

David Dean Halbert

CEODavid Dean Halbert

Employees

—

Employees—

Headquarters

Irving, Texas

HeadquartersIrving, Texas

Founded

2008

Founded2008

Employees

—

Employees—

CAI Key Statistics

Market cap

8.56B

Market cap8.56B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

536.22K

Average volume536.22K

High today

$29.08

High today$29.08

Low today

$27.70

Low today$27.70

Open price

$28.32

Open price$28.32

Volume

630.33K

Volume630.33K

52 Week high

$30.70

52 Week high$30.70

52 Week low

$21.00

52 Week low$21.00

Analyst ratings

100%

of 9 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own CAI. This list is generated using Robinhood data, and it’s not a recommendation.

Circle Internet Group

Caris Life Sciences

Why Robinhood?

Caris Life Sciences, Inc. provides diagnostics and anatomic pathology services. It develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects. Show more

CAI Key Statistics

Analyst ratings

100%

People also own

Caris Life Sciences, Inc. provides diagnostics and anatomic pathology services. It develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects.